Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer. - Fischer C; Deutsch TM; Feisst M; Rippinger N; Riedel F; Hartkopf AD; Brucker SY; Domschke C; Fremd C; Michel L; Burwinkel B; Schneeweiss A; et al. (Archives of gynecology and obstetrics, 2022)